U.S. markets closed

Emerald Health Therapeutics, Inc. (EMHTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.2073+0.0032 (+1.57%)
At close: 3:59PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.2041
Open0.1935
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1935 - 0.2101
52 Week Range0.1050 - 0.4660
Volume179,762
Avg. Volume721,537
Market Cap43.249M
Beta (5Y Monthly)1.07
PE Ratio (TTM)N/A
EPS (TTM)-0.5560
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Emerald Health Therapeutics' Cannabis Sublingual Tablet Provides Consumers with Predictable Action and Advances Defined Dose™ Offering
    CNW Group

    Emerald Health Therapeutics' Cannabis Sublingual Tablet Provides Consumers with Predictable Action and Advances Defined Dose™ Offering

    Emerald Health Therapeutics, Inc. ("Emerald") (TSXV: EMH) (OTCQX: EMHTF) has launched its new product line, SYNC™ Tabs, an innovative, naturally-flavoured ingestible offering consumers a controlled 10 mg THC dose with predictable onset and offset. This product line expands its offering under its SYNC™ Wellness brand and is the second of Emerald's Defined Dose™ products. The first provincial purchase orders have been received and, beginning April 13th, the tablets will be available to consumers at licensed cannabis retailers and online in BC, Manitoba, and Newfoundland, with Alberta to follow.

  • Emerald Health Therapeutics Establishes Partnership with Spanish Greenhouse Grower for GMP-Certified Cannabis
    Newsfile

    Emerald Health Therapeutics Establishes Partnership with Spanish Greenhouse Grower for GMP-Certified Cannabis

    Vancouver, British Columbia--(Newsfile Corp. - March 17, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has formed a partnership with Medical Plants SLU, based in Almeria, Spain, in which it will provide resources and expertise to assist Medical Plants to produce medical cannabis dried flower and 2.0 products to serve emerging legal medical cannabis markets in the EU and other countries that require high-grade GMP-certified flower or derivatives. Medical Plants ...

  • Emerald Health Therapeutics Announces Intention to List on Canadian Securities Exchange
    Newsfile

    Emerald Health Therapeutics Announces Intention to List on Canadian Securities Exchange

    Vancouver, British Columbia--(Newsfile Corp. - March 9, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") today announced that it has applied to the Canadian Securities Exchange ("CSE") to have its common shares listed for trading on the CSE. In connection with the listing of its common shares on the CSE, Emerald will apply to the TSX Venture Exchange ("TSXV") to have its common shares delisted from trading on the TSXV.Listing its ...